Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

NCT00982007 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

997

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia

Interventions

DRUG: Ferric Carboxymaltose (FCM)
DRUG: Ferrous Sulfate Tablets
DRUG: IV Iron (standard of care)
DRUG: Ferric Carboxymaltose (FCM)

Sponsor

American Regent, Inc.